erlotinib hydrochloride has been researched along with cilengitide in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 194 | 29 | 133 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | cilengitide (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 0.3087 | |
| Integrin beta-1 | Homo sapiens (human) | 1.0131 | |
| Integrin alpha-V | Homo sapiens (human) | 0.514 | |
| Integrin alpha-IIb | Homo sapiens (human) | 2.399 | |
| Integrin alpha-5 | Homo sapiens (human) | 0.9006 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Integrin beta-5 | Homo sapiens (human) | 0.4791 | |
| Integrin beta-6 | Homo sapiens (human) | 4.042 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0005 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, J; Kim, J | 1 |
1 other study(ies) available for erlotinib hydrochloride and cilengitide
| Article | Year |
|---|---|
Combination Effect of Cilengitide with Erlotinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition in Human Non-Small Cell Lung Cancer Cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Snake Venoms; Transforming Growth Factor beta1 | 2022 |